| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701490 | Journal of Thoracic Oncology | 2017 | 10 Pages |
Abstract
The cobas plasma test detected the T790M mutation in 61% of tumor tissue T790M mutation-positive patients. To mitigate the risk of false-negative plasma results, patients with a negative plasma result should undergo a tissue test where feasible.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Suzanne DPhil, James C-H. M.B.B.S., MD, Suresh S. MD, PhD, Karen BA, Sabina PhD, Susie BSc, Rachel MSc, Mireille MD, Pasi A. MD, PhD, Tetsuya MD, PhD, Glenwood D. MD,